Vanda Pharmaceuticals Inc Cash Flow Quality Index
Vanda Pharmaceuticals Inc cash flow quality index. Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow Quality Index of -14.96x as of September 2023. Operating cash flow of $-2.05 Million is below net income of $137.00K, suggesting accrual-heavy earnings not yet converted to cash. See Vanda Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Vanda Pharmaceuticals Inc (2010–2023)
Cash flow quality index of Vanda Pharmaceuticals Inc from 2010 to 2023. Historical Cash Flow Quality Index for Vanda Pharmaceuticals Inc across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Vanda Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Vanda Pharmaceuticals Inc Cash Flow Quality Index by Year (2010–2023)
Vanda Pharmaceuticals Inc cash flow quality index by year from 2010 to 2023. Year-by-year earnings quality comparison for Vanda Pharmaceuticals Inc. For the full cash flow conversion analysis, see cash flow conversion of Vanda Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 5.10x | $12.80 Million | $2.51 Million | ▲ +0.1% |
| 2022 | 5.10x | $31.98 Million | $6.28 Million | ▲ +163.1% |
| 2021 | 1.94x | $64.21 Million | $33.15 Million | ▼ -12.7% |
| 2020 | 2.22x | $51.77 Million | $23.34 Million | ▲ +458.0% |
| 2019 | 0.40x | $45.95 Million | $115.55 Million | ▼ -66.6% |
| 2018 | 1.19x | $29.99 Million | $25.21 Million | ▲ +129.4% |
| 2014 | -4.04x | $-81.55 Million | $20.19 Million | ▼ -166.6% |
| 2010 | -1.52x | $-10.90 Million | $7.19 Million | — |